Why Sorrento Therapeutics' Shares Tumbled 23.4% in September

Why Sorrento Therapeutics' Shares Tumbled 23.4% in September

What happened Shares of Sorrento Therapeutics (NASDAQ: SRNE), a biotech company that specializes in oncology and pain therapies, dropped 23.4% in September, according to data from S&P Global Intelligence.